证券代码：000777 证券简称：中核科技 公告编号：2025-059 中核苏阀科技实业股份有限公司 2025 年第四次临时股东会决议公告 本公司及董事会全体成员保证公告信息披露的内容真实、准确、完整，没有虚假记 载、误导性陈述或者重大遗漏。 特别提示： 4.会议召集人：公司董事会 5.会议主持人：公司第九届董事会董事长马瀛先生 1.本次股东会未出现否决议案的情形； 2.本次股东会未涉及变更前次股东会决议。 一、会议召开和出席情况： 1.召开时间： （1）现场会议时间：2025 年 9 月 15 日（星期一） 15:00 （2）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时间为：2025 年 9 月 15 日交易日 9:15～9:25、9:30～11:30 和 13:00～15:00；通过深圳证券交易所互联 网投票系统投票的时间为 2025 年 9 月 15 日 9:15 至 2025 年 9 月 15 日 15:00 期间的任意时 间。 2.现场会议召开地点：苏州市珠江路 501 号公司 108 会议室 3.召开方式：采用现场投票和网络投票相结合的方式 6.会议的出席情况： 本次会议以现场投票 ...

Group 1 - The core viewpoint of the article highlights the growth in China's nuclear power generation, with a projected output of 384 billion kilowatt-hours in May 2025, representing a year-on-year increase of 6.7% [1] - Cumulative nuclear power generation in China from January to May 2025 is reported at 1,969.2 billion kilowatt-hours, showing a cumulative growth of 11.5% [1] - The article references a report by Zhiyan Consulting, which provides insights into the market dynamics and investment strategies for the nuclear power industry in China from 2025 to 2031 [1] Group 2 - Listed companies in the nuclear power sector include China General Nuclear Power (003816), China National Nuclear Power (601985), and others, indicating a diverse market landscape [1] - The data presented is sourced from the National Bureau of Statistics, emphasizing the reliability of the statistics used in the analysis [1] - Zhiyan Consulting is described as a leading industry consulting firm in China, specializing in comprehensive industry research and providing tailored consulting services [1]

Company Overview - China Nuclear Technology is located in Suzhou, Jiangsu Province, and was established on July 2, 1997, with its listing date on July 10, 1997 [2] - The company's main business involves the research, design, manufacturing, and sales of industrial valves, with revenue composition as follows: 44.17% from nuclear power and nuclear chemical products, 29.26% from oil and petrochemical products, 22.16% from other valves, 3.22% from forgings and blanks, and 1.19% from other supplementary products [2] Financial Performance - For the first half of 2025, China Nuclear Technology achieved operating revenue of 704 million yuan, representing a year-on-year growth of 9.43%, and a net profit attributable to shareholders of 76.83 million yuan, with a year-on-year increase of 1.68% [2] - The company has distributed a total of 615 million yuan in dividends since its A-share listing, with 193 million yuan distributed in the last three years [3] Stock Performance - As of September 8, the stock price of China Nuclear Technology increased by 2.00%, reaching 19.89 yuan per share, with a total market capitalization of 7.626 billion yuan [1] - Year-to-date, the stock price has risen by 11.14%, but it has seen a decline of 1.19% over the last five trading days and a 6.97% drop over the last 20 days [1] - The company has appeared on the trading leaderboard once this year, with the most recent appearance on July 8, where it recorded a net buy of -15.86 million yuan [1] Shareholder Information - As of June 30, 2025, the number of shareholders for China Nuclear Technology was 77,500, an increase of 33.56% from the previous period, while the average circulating shares per person decreased by 25.13% to 4,949 shares [2] - Among the top ten circulating shareholders, Jin Ying Technology Innovation Stock A is the fourth largest with 4.97 million shares, an increase of 500,000 shares from the previous period, while Jin Ying Dividend Value Mixed A is the tenth largest with 1.77 million shares, marking a new entry [3]

Group 1 - The core viewpoint of the article indicates that China Nuclear Technology (000777.SZ) has announced that the fourth-generation reactor project in Shandong is expected to be delivered this year, while there are no delivery plans for the Lianyungang project this year [1]

Group 1 - The core viewpoint of the article indicates that China Nuclear Technology (000777.SZ) has announced that the fourth-generation reactor project in Shandong is expected to be delivered this year, while there are no delivery plans for the Lianyungang project this year [1]

Core Viewpoint - China Nuclear Technology (000777.SZ) has indicated that its current nuclear power capacity can simultaneously produce valves for 8 reactor units, with an expected increase to 10 reactor units upon completion of the third phase of construction [1] Company Summary - The company is currently capable of producing valves for 8 nuclear reactor units [1] - After the completion of the third phase of construction, the company anticipates the ability to produce valves for 10 nuclear reactor units simultaneously [1]

Group 1 - The company currently has a total nuclear power order backlog of approximately 2.9 billion yuan [1] - Within the group, the nuclear power order backlog is about 1.6 billion yuan, with new orders signed this year amounting to around 600 million yuan [1]

Group 1: Financial Performance and Orders - The company has a total of approximately ¥2.9 billion in hand nuclear power orders, with ¥1.6 billion from the group and about ¥600 million in new orders signed this year [4]. - The expected gross margin for nuclear power valves is closely related to the product output structure, with variations based on pricing ability, cost composition, and market competition [3]. - The company aims to maintain a steady performance in 2025, with a focus on optimizing business structure and enhancing core competitiveness [12]. Group 2: Production Capacity and Expansion - The company’s nuclear power production capacity can currently support the production of valves for 8 reactor units, with plans to increase this to 10 units after the completion of the third phase of construction by mid-2026 [6]. - The first two phases of capacity expansion have been completed, enhancing testing, processing, and storage capabilities [6]. - The company is actively pursuing capacity expansion in the nuclear sector to meet strategic development opportunities [14]. Group 3: Technological Development and Market Strategy - The company is focusing on high-end valve localization strategies and aims to support the development of fusion reactor valve equipment [7]. - It has a comprehensive product range in both nuclear and non-nuclear fields, with strong research and product integration capabilities [14]. - The company is committed to continuous technological innovation and digital transformation to enhance core competitiveness and expand market share [11]. Group 4: Industry Engagement and Project Involvement - The company has been actively involved in coal chemical projects since 2014, achieving significant milestones in valve development for coal chemical processes [9]. - Recent bids for projects include upgrades for coal-to-oil facilities and hydrogenation units, with successful order acquisitions [10]. - The company has a history of significant orders in the coal chemical sector, collaborating with major clients in the industry [10].

Core Viewpoint - The company, China Nuclear Technology (000777.SZ), is currently experiencing good overall capacity utilization and is focusing on expanding its production capacity in several key areas to meet upcoming strategic opportunities in the nuclear power sector [1] Group 1: Capacity Expansion Focus - The company aims to accelerate capacity expansion and automation in the nuclear sector to address challenges related to capacity matching during the strategic development phase of nuclear power [1] - In the oil and petrochemical sector, the company is focusing on intelligent upgrades and equipment renewal as a core strategy [1] - In the energy and utilities sector, the company plans to implement phased construction of facilities and equipment investment to actively develop conventional and new product capacities [1]

Core Viewpoint - The performance of the Zhongzheng 2000 ETF Enhanced (159556) has shown a decline of 2.20% as of the midday close on September 2, with a trading volume of 2.0863 million yuan [1] Group 1: Fund Performance - The Zhongzheng 2000 ETF Enhanced (159556) has a performance benchmark based on the Zhongzheng 2000 Index return [1] - Since its establishment on December 27, 2023, the fund has achieved a return of 18.85% [1] - The fund's return over the past month is reported at 9.45% [1] Group 2: Major Holdings - Major stocks in the fund include: - Zhenhua New Materials, down 1.72% - Hengbao Co., down 8.57% - Yongding Co., down 6.21% - Yong'an Pharmaceutical, down 2.03% - Xuguang Electronics, down 1.07% - Zhongke Technology, down 1.89% - Juguang Technology, down 3.61% - Huitong Energy, down 2.42% - Xinke Materials, down 2.41% - Batian Co., down 3.71% [1]